TIVA Mobile Health Intervention for Family Caregivers
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversidade do Porto
About this trial
This pilot study aims to evaluate the feasibility, usability, and preliminary effects of the TIVA mobile health intervention in promoting positive mental health among family caregivers of older adults. TIVA is a culturally adapted mobile application based on Lluch's Positive Mental Health model and designed to support caregivers through daily activities, motivational messages, relaxation strategies, and psychoeducational content over a four-week intervention period.
A pilot randomized controlled study with parallel allocation will be conducted involving family caregivers recruited in community and primary healthcare settings in Portugal. Participants will be allocated either to the TIVA intervention group or to a usual care control group. Outcomes will include positive mental health, caregiver burden, usability, satisfaction, adherence, and acceptability. Data will be collected at baseline, post-intervention, and follow-up.
This study intends to contribute to the development of accessible digital mental health strategies to support family caregivers and promote healthy ageing.
Eligibility criteria
Qualifiers
Adults aged 18 years or older.
Unpaid family caregivers of a person with chronic illness, disability, or dependency.
Providing regular caregiving assistance for at least 4 months.
Living in Portugal.
Disqualifiers
Severe cognitive impairment.
difficulties preventing independent use of the application or completion of study assessments.
Severe psychiatric disorder or acute mental health crisis interfering with participation.
Participation in another structured caregiver support or psychological intervention during the study period.
Trial design
Treatments tested in this trial
- TIVA Mobile Application
Treatment groups
80 Participants
are divided into 2 treatment groupsSponsors and collaborators
Universidade do Porto
Lead sponsor
Instituto de Ciências Biomédicas Abel Salazar
Collaborator
Source ClinicalTrials.gov